We now demonstrate an IFN-inducible blood transcriptional signature in TB and sarcoidosis patients using larger cohorts of independently recruited participants and new findings of a distinct signature from pneumonia and lung cancer. The gene discussed is IFNA1; the disease is lung carcinoma.